News

The protein language model is trained solely on paired human antibody sequences with scalable applications in antibody ...
An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor ...
CAR-T cells are specialized immune cells genetically modified to recognize and attack cancer cells. Researchers at Nagoya ...
The most common cancer in women — and one of the deadliest — may have finally met its match. Development of a breakthrough ...
Results from the Phase II VLA1553-221 trial show that a full dose of Ixchiq demonstrated a 96.5% seroresponse rate in ...
The FDA recently granted fast track designation to PHST001, an investigational anti-CD24 monoclonal antibody, for the ...
When it comes to vaccines, where they go into your body can make a surprising difference in how well they work. Scientists in ...
A new study reveals that the SARS-CoV-2 nucleocapsid protein can spread from infected to uninfected cells, triggering an ...
Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing ...
Canine leishmaniosis, caused by Leishmania infantum, is a vector-borne disease. The immune response in infected dogs determines the clinical outcome, with a strong cell-mediated immune response linked ...
IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV)Antibody levels remained high after six months in both dose groups, ...
Rina-S led to a 50% response rate, including two complete responses, in heavily pretreated advanced endometrial cancer, ...